In conjunction with the quality measures and the expanded bundle proposals, CMS is also soliciting public comments on other effective approaches to value-based purchasing that would promote high quality care and encourage hospital efficiencies in light of the continued growth in hospital outpatient expenditures.
CMS is proposing to pay separately for drugs, biologicals, and therapeutic radiopharmaceuticals costing more than $60 or more per day in CY 2008, consistent with the historical $50 threshold but updated for inflation. Payments for other drugs would continue to be bundled into payments for their associated procedures. However, as in past years, CMS is proposing to make an exception to the bundling policy for certain anti-nausea drugs often used by cancer patients to counteract side effects of treatment.
Ad Statistics
Times Displayed: 30288
Times Visited: 753 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
Comments on the proposed rule will be accepted until September 14, and a final OPPS/ASC payment rule will be published later this fall.
For the text of the ASC final revised payment system rule see www.cms.hhs.gov/ASCPayment/
For the text of the combined OPPS/ASC proposed rule, see: www.cms.hhs.gov/HospitalOutpatientPPS/HORD/list.asp#TopOfPage
For Fact Sheets on the final ASC rule and the combined OPPS/ASC proposed rule, see:
www.cms.hhs.gov/apps/media/fact_sheets.asp .
Back to HCB News
